Perspective discusses development of affordable quinoline-based antimalarials, highlighting safety and innovative strategies.
performance. Emerging safety considerations, such as cardiotoxicity (hERG inhibition), hepatotoxicity, and metabolite formation, are also highlighted. In addition, key challenges and future directions are discussed, including exploration of new biological targets and the application of modern discovery strategies such as molecular hybridization, drug repurposing, prodrug design, and ionic liquids. Overall, this perspective aims to provide insights that support the continued development of affordable, safe, and effective quinoline-based antimalarial therapeutics.
No takes yet. Share an insight, caveat, or question.
Guang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: